|
Friday 15th August 2003 |
Text too small? |
A closer look, however, reveals operating revenue was down 15% to $50.5 million against the previous period and much of the profit increase was attributable to a one-off cost of $528,000 during the same six months a year ago.
The company has operated in a torrid environment, though, and has undergone a rigorous cost-cutting programme, including downsizing inventory and reducing staff overheads.
With that in mind, most of Renaissance's troubles seem to be behind it, in particular the company's Conduit subsidiary, which can now cover costs with on-going revenues.
However, as the directors' noted at the time of the result, the PC and software market remains subdued while the relative strength of the Kiwi dollar and competitive pricing in the global IT market continue to put pressure on margins.
The company's emphasis on exclusive, value-added brands should at least produce more predictable results, the directors noted.
This year the shares have climbed from just over 20c to their current price of about 45c. But they are a long way from the dizzying highs of $1.20 in early 2001.
No comments yet
HGH Ltd Results for the 6 months ended 1 February 2026
March 27th Morning Report
CDC investor presentation and guidance update
PFI - Potential Bond Offer by PFI
MCY - Mercury Green Bond offer - interest rate set
March 25th Morning Report
AFT - Chief Financial Officer update
KMD Brands: Response to Stokehouse transaction concept
March 24th Morning Report
MCY - Mercury launches retail Green Bond offer